Results 111 to 120 of about 7,431 (174)

A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model

, 2019
Edward M. Kennedy, Stuart Dowall, Francisco J. Salguero, Peter Yeates, Marilyn Aram, Roger Hewson   +5 more
openalex   +1 more source

Comparative Evaluation of Modified Vaccinia Ankara as a Surrogate Virus for Disinfectant Efficacy Testing Against AIV, FMDV, and ASFV. [PDF]

Viruses
Song S, Kim SJ, Shin KS, Park SH, Joo YY, Han B, Lee CY, Park GW, Ku HO, Jeong W, Park CK.   +10 more
europepmc   +1 more source

Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.

JAMA, 2023
Deng L, Lopez LK, Glover C, Cashman P, Reynolds R, Macartney K, Wood N.   +6 more
europepmc   +1 more source

Purification of modified vaccinia virus Ankara from suspension cell culture [PDF]

, 2015
Ingo Jordan, Diana Weimer, Stefan Iarusso, Holger Bernhardt, Verena Lohr, Volker Sandig   +5 more
openalex   +1 more source

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors. [PDF]

J Immunother Cancer, 2021
Tenesaca S, Vasquez M, Alvarez M, Otano I, Fernandez-Sendin M, Di Trani CA, Ardaiz N, Gomar C, Bella A, Aranda F, Medina-Echeverz J, Melero I, Berraondo P.   +12 more
europepmc   +1 more source

Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate model. [PDF]

Nat Commun
Herate C, Ferrier-Rembert A, Relouzat F, Gallouët AS, Pascal Q, Letscher H, Cavarelli M, Dereuddre-Bosquet N, Gros W, Delache B, Langlois S, Timera H, Jarjaval F, Bossevot L, Ludot C, Brua C, Lechemia M, Ferraris O, Silvestre N, Le Grand R, Tournier JN.   +20 more
europepmc   +1 more source

Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine.

JAMA, 2022
Hazra A, Rusie L, Hedberg T, Schneider JA.   +3 more
europepmc   +1 more source

Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations. [PDF]

Vaccines (Basel)
Suñer C, Escrig-Sarreta R, Galván-Casas C, Matos E, Gabster A, Wolff M, Ouchi D, Alemany A, Sánchez H, Huaman S, Bejarano D, Carrés-Esteve L, Santiago-Fernández C, Corral-Rubio J, Mendoza A, Rivero À, Descalzo V, Orviz E, Martínez-Riveros H, Méndez-Boo L, Cabezas C, Arce-Arnáez A, Marks M, Mitjà O, Remain Study Group.   +24 more
europepmc   +1 more source

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox. [PDF]

Lancet Reg Health Eur
Shen M, Zhang L.
europepmc   +1 more source

Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. [PDF]

Biotechnol J, 2021
Gränicher G, Tapia F, Behrendt I, Jordan I, Genzel Y, Reichl U.   +5 more
europepmc   +1 more source